Guo-Bao Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guo-Bao Hong has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Hua Xiao
Department of Nephrology, The Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong, China
2 shared publicationsKai Liu
Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China
2 shared publicationsHong-Hao Meng
Department of Intensive Care Unit, Nanfang Hospital, Southern Medical University, Guangdong, China
1 shared publication- Xinzhou Zhang
Department of Nephrology, Shenzhen Key Laboratory of Kidney Diseases, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
1 shared publication - Xinzhou Zhang
Department of Nephrology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital
1 shared publication Yun-Peng Peng
Emergency Medicine Department, Shenzhen Bao’an District Kong Hai Hospital, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1570723
Association between self-reported sleep disorders and prevalence of chronic kidney disease in a nationally representative sample of U.S. adults
Background: Chronic kidney disease (CKD) is associated with various health complications, including sleep disorders. Understanding the relationship between CKD and sleep disturbances is essential for improving patient management and outcomes in this population. Patients and methods: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) across two cycles (2015–2016 and 2017-2018), involving 4758 participants aged 20 years and older. Sleep disorders were evaluated via targeted questions from the Sleep Disorders Questionnaire. Chronic kidney disease (CKD) was classified by low estimated glomerular filtration rate (eGFR) and proteinuria. Logistic regression analyses examined the association between sleep disorders and CKD, adjusting for demographic and lifestyle confounders. Results: Among 4,758 participants, 863 (14%) were diagnosed with chronic kidney disease (CKD). Elevated C-reactive protein (CRP) levels and differential leukocyte counts were observed in the CKD cohort. CKD was associated with increased reports of snoring, sleep apnea, and sleep disturbances, along with higher fatigue levels. A significant positive association between CKD and sleep difficulties persisted in adjusted models. Infrequent snoring (1–2 times per week) demonstrated a negative association, whereas excessive daytime sleepiness (16–30 times/month) correlated positively with CKD. Significant associations between sleep disorders and CKD were observed in participants aged <60, with a BMI <28 kg/m², normal blood pressure, and CRP ≥1.8 mg/L. Sleep disorders were found to be correlated with obesity, hypertension, diabetes, CKD, and proteinuria. Notably, CKD patients with sleep difficulties had markedly elevated CRP levels compared to those without sleep issues, while other inflammatory markers were similarly elevated (P < 0.001). Conclusion: Patients with chronic kidney disease experience higher rates of sleep issues, highlighting the importance of addressing these problems in CKD management.
- 18 November 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1570723
Open AccessAssociation between self-reported sleep disorders and prevalence of chronic kidney disease in a nationally representative sample of U.S. adults
Background: Chronic kidney disease (CKD) is associated with various health complications, including sleep disorders. Understanding the relationship between CKD and sleep disturbances is essential for improving patient management and outcomes in this population. Patients and methods: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) across two cycles (2015–2016 and 2017-2018), involving 4758 participants aged 20 years and older. Sleep disorders were evaluated via targeted questions from the Sleep Disorders Questionnaire. Chronic kidney disease (CKD) was classified by low estimated glomerular filtration rate (eGFR) and proteinuria. Logistic regression analyses examined the association between sleep disorders and CKD, adjusting for demographic and lifestyle confounders. Results: Among 4,758 participants, 863 (14%) were diagnosed with chronic kidney disease (CKD). Elevated C-reactive protein (CRP) levels and differential leukocyte counts were observed in the CKD cohort. CKD was associated with increased reports of snoring, sleep apnea, and sleep disturbances, along with higher fatigue levels. A significant positive association between CKD and sleep difficulties persisted in adjusted models. Infrequent snoring (1–2 times per week) demonstrated a negative association, whereas excessive daytime sleepiness (16–30 times/month) correlated positively with CKD. Significant associations between sleep disorders and CKD were observed in participants aged <60, with a BMI <28 kg/m², normal blood pressure, and CRP ≥1.8 mg/L. Sleep disorders were found to be correlated with obesity, hypertension, diabetes, CKD, and proteinuria. Notably, CKD patients with sleep difficulties had markedly elevated CRP levels compared to those without sleep issues, while other inflammatory markers were similarly elevated (P < 0.001). Conclusion: Patients with chronic kidney disease experience higher rates of sleep issues, highlighting the importance of addressing these problems in CKD management.
- 15 November 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 999-1008
Association between the use of loop diuretics and prognosis in critically ill patients with acute kidney injury: a retrospective propensity score-matched cohort study
Background The role of loop diuretics in patients with acute kidney injury (AKI) is controversial. This study examined the association between the use of loop diuretics and prognosis in critically ill patients with AKI. Methods This study used data from the medical information mart for the intensive care IV database. Adult critically ill patients with AKI were included in the analysis. Patients were partitioned into two groups based on their use of loop diuretics in the ICU, and potentially confounding variables between the two groups were balanced using propensity score matching (PSM). We used time-dependent Cox proportional hazards regression, logistic regression, and Hodges–Lehman estimator to assess the impact of loop diuretics on all-cause mortality, renal replacement therapy (RRT) use, and the length of hospital stay, respectively. Results This study included a cohort of 19,671 patients. After PSM, both groups consisted of 6200 patients. The use of loop diuretics was associated with a lower risk of in-hospital mortality (HR, 0.672; 95% CI 0.597–0.757; P < 0.001), lower in-ICU mortality (HR, 0.375; 95% CI 0.315–0.446; P < 0.001), and lower odds of in-hospital RRT (OR, 0.472; 95% CI 0.400–0.555; P < 0.001). A sensitivity analysis using the original cohort (HR, 0.624; 95% CI 0.561–0.693; P < 0.001) and weighted cohort (HR, 0.654; 95% CI 0.582–0.736; P < 0.001) also demonstrated lower in-hospital all-cause mortality. Conclusions The use of loop diuretics is associated with a substantial reduction in mortality among critically ill patients with AKI.
- 15 November 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 999-1008
Association between the use of loop diuretics and prognosis in critically ill patients with acute kidney injury: a retrospective propensity score-matched cohort study
Background The role of loop diuretics in patients with acute kidney injury (AKI) is controversial. This study examined the association between the use of loop diuretics and prognosis in critically ill patients with AKI. Methods This study used data from the medical information mart for the intensive care IV database. Adult critically ill patients with AKI were included in the analysis. Patients were partitioned into two groups based on their use of loop diuretics in the ICU, and potentially confounding variables between the two groups were balanced using propensity score matching (PSM). We used time-dependent Cox proportional hazards regression, logistic regression, and Hodges–Lehman estimator to assess the impact of loop diuretics on all-cause mortality, renal replacement therapy (RRT) use, and the length of hospital stay, respectively. Results This study included a cohort of 19,671 patients. After PSM, both groups consisted of 6200 patients. The use of loop diuretics was associated with a lower risk of in-hospital mortality (HR, 0.672; 95% CI 0.597–0.757; P < 0.001), lower in-ICU mortality (HR, 0.375; 95% CI 0.315–0.446; P < 0.001), and lower odds of in-hospital RRT (OR, 0.472; 95% CI 0.400–0.555; P < 0.001). A sensitivity analysis using the original cohort (HR, 0.624; 95% CI 0.561–0.693; P < 0.001) and weighted cohort (HR, 0.654; 95% CI 0.582–0.736; P < 0.001) also demonstrated lower in-hospital all-cause mortality. Conclusions The use of loop diuretics is associated with a substantial reduction in mortality among critically ill patients with AKI.